Yan Aalto
Impact in
- Cancer Research top 10%
- Cancer Genomics and Diagnostics
- Ophthalmology top 5%
- Ocular Oncology and Treatments
Papers in
-
- Protein Degradation and Inhibitors 2
-
- Sarcoma Diagnosis and Treatment 4
- Co-authors
- Sakari Knuutila (11 shared papers)Sakari Knuutila (12 shared papers)Olle Larsson (4 shared papers)Stefan Seregard (1 shared paper)Bálint Nagy (6 shared papers)Ying Zhu (3 shared papers)Wael El‐Rifai (2 shared papers)Marcelo L. Larramendy (3 shared papers)
In The Last Decade
Yan Aalto
24 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 75
- Cancer Research 256
- Ophthalmology 149
- Genetics 154
- Oncology 368
- Pathology and Forensic Medicine 242
Countries citing papers authored by Yan Aalto
This map shows the geographic impact of Yan Aalto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yan Aalto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yan Aalto more than expected).
Fields of papers citing papers by Yan Aalto
This network shows the impact of papers produced by Yan Aalto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yan Aalto. The network helps show where Yan Aalto may publish in the future.
Co-authors
The 25 scholars most cited alongside Yan Aalto, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1999 | 332 | |
| 2 | Concomitant loss of chromosome 3 and whole arm losses and gains of chromosome 1, 6, or 8 in metastasizing primary uveal melanoma. | 2001 | 158 |
| 3 | 2004 | 94 | |
| 4 | 2003 | 89 | |
| 5 | 2001 | 65 | |
| 6 | 2000 | 63 | |
| 7 | 2002 | 51 | |
| 8 | 2002 | 40 | |
| 9 | 1999 | 33 | |
| 10 | 2004 | 30 | |
| 11 | 2002 | 29 | |
| 12 | 2001 | 25 | |
| 13 | 2001 | 24 | |
| 14 | 1999 | 24 | |
| 15 | 2003 | 23 | |
| 16 | 2002 | 20 | |
| 17 | 2002 | 19 | |
| 18 | 1999 | 13 | |
| 19 | 2003 | 13 | |
| 20 | Lymphotoxin beta expression is high in chronic lymphocytic leukemia but low in small lymphocytic lymphoma: a quantitative real-time reverse transcriptase polymerase chain reaction analysis. | 2003 | 12 |
About Yan Aalto
Yan Aalto is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Pathology and Forensic Medicine, Oncology and Cancer Research, having authored 25 papers that have together received 1.2k indexed citations. Recurring topics across this work include Sarcoma Diagnosis and Treatment (4 papers), Cancer Genomics and Diagnostics (4 papers), Genomic variations and chromosomal abnormalities (4 papers), Chronic Lymphocytic Leukemia Research (3 papers), Lymphoma Diagnosis and Treatment (3 papers), Neuroendocrine Tumor Research Advances (3 papers), Neuroblastoma Research and Treatments (2 papers) and Protein Degradation and Inhibitors (2 papers). The work is most often cited by research in Cancer Research (256 citations), Ophthalmology (149 citations), Genetics (154 citations), Oncology (368 citations) and Pathology and Forensic Medicine (242 citations). Yan Aalto has collaborated with scholars based in Finland, Sweden and Hungary. Frequent co-authors include Sakari Knuutila, Sakari Knuutila, Olle Larsson, Stefan Seregard, Bálint Nagy, Ying Zhu, Wael El‐Rifai, Marcelo L. Larramendy, Tamara Lushnikova and Juhani Vilpo. Their work appears in journals such as Oncogene, British Journal of Haematology, Genes Chromosomes and Cancer, Leukemia and Analytical Cellular Pathology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.